Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences

Author(s): Najah Abi-Gerges*, Paul E. Miller, Andre Ghetti

Journal Name: Current Pharmaceutical Biotechnology

Volume 21 , Issue 9 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


In preclinical drug development, accurate prediction of drug effects on the human heart is critically important, whether in the context of cardiovascular safety or for the purpose of modulating cardiac function to treat heart disease. Current strategies have significant limitations, whereby, cardiotoxic drugs can escape detection or potential life-saving therapies are abandoned due to false positive toxicity signals. Thus, new and more reliable translational approaches are urgently needed to help accelerate the rate of new therapy development. Renewed efforts in the recovery of human donor hearts for research and in cardiomyocyte isolation methods, are providing new opportunities for preclinical studies in adult primary cardiomyocytes. These cells exhibit the native physiological and pharmacological properties, overcoming the limitations presented by artificial cellular models, animal models and have great potential for providing an excellent tool for preclinical drug testing. Adult human primary cardiomyocytes have already shown utility in assessing drug-induced cardiotoxicity risk and helping in the identification of new treatments for cardiac diseases, such as heart failure and atrial fibrillation. Finally, strategies with actionable decision-making trees that rely on data derived from adult human primary cardiomyocytes will provide the holistic insights necessary to accurately predict human heart effects of drugs.

Keywords: Small molecule drug discovery, human heart, adult human primary cardiomyocytes, cardiotoxicity, atrial fibrillation, heart failure, translational sciences.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [787 - 806]
Pages: 20
DOI: 10.2174/1389201021666191210142023
Price: $65

Article Metrics

PDF: 11